New Student Offer- Use Code HELLO

Register Now

Canada Approves the Use of Covifenz

Published on March 01, 2022
Current Context: Canada has approved the use of Covifenz.
Canada Approves the Use of Covifenz
  • The Covifenz is the world’s first plant-derived Covid-19 vaccine.
  • It is jointly developed by Medicago Inc. and GlaxoSmithKline Plc.
  • The vaccine dose can be given to adults between 18 to 64 age.
  • It is made from plant-based proteins and makes use of Glaxo’s adjuvant that contains DL-alpha-tocopherol, squalene, polysorbate 80, phosphate-buffered saline.
  • It also includes potassium phosphate monobasic anhydrous, anhydrous sodium chloride, sodium phosphate dibasic anhydrous, and water for injection.
  • The company used living plants as bioreactors to produce a particle that mimics the target virus. Further, the virus-like particles were developed by undergoing various processes like synthesis, infiltration, incubation, harvest, and purification.
  • Static Part: 
    • Capital of Canada: Ottawa
    • Currency of Canada: Canadian dollar

Can I help you?

ramandeep singh

Hey I am Ramandeep Singh. I am determined to help students preparing for RBI, SEBI, NABARD and IBPS exams. Do you want me to help you ?

Join my class here
    Follow me:
Close Menu
Close Menu